HEADER OXIDOREDUCTASE 15-NOV-18 6I6C
TITLE SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 2
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SEPIAPTERIN REDUCTASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: SPR;
COMPND 5 EC: 1.1.1.153;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: SPR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: NICO;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28
KEYWDS SEPIAPTERIN-REDUCTASE, OXIDOREDUCTASE, PROTEROS BIOSTRUCTURES GMBH
EXPDTA X-RAY DIFFRACTION
AUTHOR J.ALEN,M.SCHADE,M.WAGENER,M.BLAESSE
REVDAT 3 15-MAY-24 6I6C 1 REMARK
REVDAT 2 24-JUL-19 6I6C 1 JRNL
REVDAT 1 10-JUL-19 6I6C 0
JRNL AUTH J.ALEN,M.SCHADE,M.WAGENER,F.CHRISTIAN,S.NORDHOFF,B.MERLA,
JRNL AUTH 2 T.R.DUNKERN,G.BAHRENBERG,P.RATCLIFFE
JRNL TITL FRAGMENT-BASED DISCOVERY OF NOVEL POTENT SEPIAPTERIN
JRNL TITL 2 REDUCTASE INHIBITORS.
JRNL REF J.MED.CHEM. V. 62 6391 2019
JRNL REFN ISSN 0022-2623
JRNL PMID 31244106
JRNL DOI 10.1021/ACS.JMEDCHEM.9B00218
REMARK 2
REMARK 2 RESOLUTION. 1.72 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0155
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 63.98
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0
REMARK 3 NUMBER OF REFLECTIONS : 48018
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.152
REMARK 3 R VALUE (WORKING SET) : 0.149
REMARK 3 FREE R VALUE : 0.206
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200
REMARK 3 FREE R VALUE TEST SET COUNT : 2640
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.72
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.77
REMARK 3 REFLECTION IN BIN (WORKING SET) : 3552
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.16
REMARK 3 BIN R VALUE (WORKING SET) : 0.2610
REMARK 3 BIN FREE R VALUE SET COUNT : 191
REMARK 3 BIN FREE R VALUE : 0.3410
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3947
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 168
REMARK 3 SOLVENT ATOMS : 235
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.17
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.15000
REMARK 3 B22 (A**2) : -0.08000
REMARK 3 B33 (A**2) : 0.23000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.196
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.113
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.623
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4245 ; 0.010 ; 0.019
REMARK 3 BOND LENGTHS OTHERS (A): 4160 ; 0.002 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5781 ; 1.681 ; 2.048
REMARK 3 BOND ANGLES OTHERS (DEGREES): 9547 ; 1.699 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 545 ; 5.830 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 162 ;37.927 ;23.889
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 708 ;11.093 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 34 ;20.833 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 669 ; 0.085 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4764 ; 0.005 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 927 ; 0.003 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2127 ; 3.124 ; 3.202
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2126 ; 3.118 ; 3.201
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2664 ; 3.255 ; 5.403
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2665 ; 3.257 ; 5.403
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2118 ; 4.361 ; 3.845
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2118 ; 4.358 ; 3.845
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3109 ; 4.619 ; 6.189
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4588 ; 4.419 ;30.620
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4559 ; 4.401 ;30.479
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): 8405 ; 2.869 ; 3.000
REMARK 3 SPHERICITY; FREE ATOMS (A**2): 149 ;19.918 ; 5.000
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 8418 ; 7.464 ; 5.000
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 6I6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-NOV-18.
REMARK 100 THE DEPOSITION ID IS D_1200012885.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-APR-17
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X06SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50658
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720
REMARK 200 RESOLUTION RANGE LOW (A) : 63.980
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0
REMARK 200 DATA REDUNDANCY : 3.500
REMARK 200 R MERGE (I) : 0.04300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.9500
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97
REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7
REMARK 200 DATA REDUNDANCY IN SHELL : 3.50
REMARK 200 R MERGE FOR SHELL (I) : 0.39400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.15
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20.00 %W/V PEG 3350, 0.10 M BIS-TRIS
REMARK 280 PROPAN PH=6.50, 0.10 M NABR, VAPOR DIFFUSION, TEMPERATURE 293.15K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.95650
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.60700
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.66050
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.60700
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.95650
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.66050
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 7960 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 19880 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -14
REMARK 465 GLY A -13
REMARK 465 HIS A -12
REMARK 465 HIS A -11
REMARK 465 HIS A -10
REMARK 465 HIS A -9
REMARK 465 HIS A -8
REMARK 465 ARG A 58
REMARK 465 SER A 59
REMARK 465 LYS A 261
REMARK 465 MET B -14
REMARK 465 GLY B -13
REMARK 465 HIS B -12
REMARK 465 HIS B -11
REMARK 465 HIS B -10
REMARK 465 HIS B -9
REMARK 465 HIS B -8
REMARK 465 HIS B -7
REMARK 465 GLU B -6
REMARK 465 ASN B -5
REMARK 465 LEU B -4
REMARK 465 TYR B -3
REMARK 465 PHE B -2
REMARK 465 GLN B -1
REMARK 465 GLY B 0
REMARK 465 MET B 1
REMARK 465 GLU B 2
REMARK 465 GLY B 3
REMARK 465 LYS B 261
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLU A 73 CD OE1 OE2
REMARK 480 ARG A 84 CG CD NE CZ NH1 NH2
REMARK 480 GLU A 85 CD OE1 OE2
REMARK 480 LYS A 90 CG CD CE NZ
REMARK 480 GLN A 119 CD OE1 NE2
REMARK 480 LYS A 140 NZ
REMARK 480 LYS A 247 NZ
REMARK 480 GLU B 57 CG CD OE1 OE2
REMARK 480 SER B 59 OG
REMARK 480 GLU B 73 CD OE1 OE2
REMARK 480 LYS B 109 NZ
REMARK 480 MET B 218 CE
REMARK 480 LYS B 220 CG CD CE NZ
REMARK 480 LYS B 228 CE NZ
REMARK 480 LYS B 230 CD CE NZ
REMARK 480 GLU B 246 CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 65 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 156 -156.89 -101.23
REMARK 500 ARG B 58 -81.92 -24.54
REMARK 500 SER B 156 -157.32 -107.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue H4H A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 304
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue H4H B 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 303
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 304
REMARK 800
REMARK 800 SITE_IDENTIFIER: AD1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 305
REMARK 800
REMARK 800 SITE_IDENTIFIER: AD2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 306
DBREF 6I6C A 1 261 UNP P35270 SPRE_HUMAN 1 261
DBREF 6I6C B 1 261 UNP P35270 SPRE_HUMAN 1 261
SEQADV 6I6C MET A -14 UNP P35270 INITIATING METHIONINE
SEQADV 6I6C GLY A -13 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS A -12 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS A -11 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS A -10 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS A -9 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS A -8 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS A -7 UNP P35270 EXPRESSION TAG
SEQADV 6I6C GLU A -6 UNP P35270 EXPRESSION TAG
SEQADV 6I6C ASN A -5 UNP P35270 EXPRESSION TAG
SEQADV 6I6C LEU A -4 UNP P35270 EXPRESSION TAG
SEQADV 6I6C TYR A -3 UNP P35270 EXPRESSION TAG
SEQADV 6I6C PHE A -2 UNP P35270 EXPRESSION TAG
SEQADV 6I6C GLN A -1 UNP P35270 EXPRESSION TAG
SEQADV 6I6C GLY A 0 UNP P35270 EXPRESSION TAG
SEQADV 6I6C MET B -14 UNP P35270 INITIATING METHIONINE
SEQADV 6I6C GLY B -13 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS B -12 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS B -11 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS B -10 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS B -9 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS B -8 UNP P35270 EXPRESSION TAG
SEQADV 6I6C HIS B -7 UNP P35270 EXPRESSION TAG
SEQADV 6I6C GLU B -6 UNP P35270 EXPRESSION TAG
SEQADV 6I6C ASN B -5 UNP P35270 EXPRESSION TAG
SEQADV 6I6C LEU B -4 UNP P35270 EXPRESSION TAG
SEQADV 6I6C TYR B -3 UNP P35270 EXPRESSION TAG
SEQADV 6I6C PHE B -2 UNP P35270 EXPRESSION TAG
SEQADV 6I6C GLN B -1 UNP P35270 EXPRESSION TAG
SEQADV 6I6C GLY B 0 UNP P35270 EXPRESSION TAG
SEQRES 1 A 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE
SEQRES 2 A 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU
SEQRES 3 A 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA
SEQRES 4 A 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU
SEQRES 5 A 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU
SEQRES 6 A 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL
SEQRES 7 A 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU
SEQRES 8 A 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO
SEQRES 9 A 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY
SEQRES 10 A 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER
SEQRES 11 A 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU
SEQRES 12 A 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA
SEQRES 13 A 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN
SEQRES 14 A 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP
SEQRES 15 A 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU
SEQRES 16 A 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL
SEQRES 17 A 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN
SEQRES 18 A 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG
SEQRES 19 A 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL
SEQRES 20 A 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU
SEQRES 21 A 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE
SEQRES 22 A 276 TYR ASP LYS
SEQRES 1 B 276 MET GLY HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE
SEQRES 2 B 276 GLN GLY MET GLU GLY GLY LEU GLY ARG ALA VAL CYS LEU
SEQRES 3 B 276 LEU THR GLY ALA SER ARG GLY PHE GLY ARG THR LEU ALA
SEQRES 4 B 276 PRO LEU LEU ALA SER LEU LEU SER PRO GLY SER VAL LEU
SEQRES 5 B 276 VAL LEU SER ALA ARG ASN ASP GLU ALA LEU ARG GLN LEU
SEQRES 6 B 276 GLU ALA GLU LEU GLY ALA GLU ARG SER GLY LEU ARG VAL
SEQRES 7 B 276 VAL ARG VAL PRO ALA ASP LEU GLY ALA GLU ALA GLY LEU
SEQRES 8 B 276 GLN GLN LEU LEU GLY ALA LEU ARG GLU LEU PRO ARG PRO
SEQRES 9 B 276 LYS GLY LEU GLN ARG LEU LEU LEU ILE ASN ASN ALA GLY
SEQRES 10 B 276 SER LEU GLY ASP VAL SER LYS GLY PHE VAL ASP LEU SER
SEQRES 11 B 276 ASP SER THR GLN VAL ASN ASN TYR TRP ALA LEU ASN LEU
SEQRES 12 B 276 THR SER MET LEU CYS LEU THR SER SER VAL LEU LYS ALA
SEQRES 13 B 276 PHE PRO ASP SER PRO GLY LEU ASN ARG THR VAL VAL ASN
SEQRES 14 B 276 ILE SER SER LEU CYS ALA LEU GLN PRO PHE LYS GLY TRP
SEQRES 15 B 276 ALA LEU TYR CYS ALA GLY LYS ALA ALA ARG ASP MET LEU
SEQRES 16 B 276 PHE GLN VAL LEU ALA LEU GLU GLU PRO ASN VAL ARG VAL
SEQRES 17 B 276 LEU ASN TYR ALA PRO GLY PRO LEU ASP THR ASP MET GLN
SEQRES 18 B 276 GLN LEU ALA ARG GLU THR SER VAL ASP PRO ASP MET ARG
SEQRES 19 B 276 LYS GLY LEU GLN GLU LEU LYS ALA LYS GLY LYS LEU VAL
SEQRES 20 B 276 ASP CYS LYS VAL SER ALA GLN LYS LEU LEU SER LEU LEU
SEQRES 21 B 276 GLU LYS ASP GLU PHE LYS SER GLY ALA HIS VAL ASP PHE
SEQRES 22 B 276 TYR ASP LYS
HET NAP A 301 48
HET H4H A 302 35
HET EDO A 303 4
HET EDO A 304 4
HET EDO A 305 4
HET NAP B 301 48
HET H4H B 302 22
HET EDO B 303 4
HET EDO B 304 4
HET EDO B 305 4
HET EDO B 306 4
HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
HETNAM H4H (1~{R},2~{S},4~{S})-~{N}-(3-CHLORANYL-4-CYANO-PHENYL)
HETNAM 2 H4H SULFONYLBICYCLO[2.2.1]HEPTANE-2-CARBOXAMIDE
HETNAM EDO 1,2-ETHANEDIOL
HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE
HETSYN EDO ETHYLENE GLYCOL
FORMUL 3 NAP 2(C21 H28 N7 O17 P3)
FORMUL 4 H4H 2(C15 H15 CL N2 O3 S)
FORMUL 5 EDO 7(C2 H6 O2)
FORMUL 14 HOH *235(H2 O)
HELIX 1 AA1 HIS A -7 GLN A -1 5 7
HELIX 2 AA2 ARG A 17 LEU A 30 1 14
HELIX 3 AA3 ASN A 43 GLU A 57 1 15
HELIX 4 AA4 ALA A 72 LEU A 86 1 15
HELIX 5 AA5 GLY A 110 LEU A 114 5 5
HELIX 6 AA6 ASP A 116 LEU A 128 1 13
HELIX 7 AA7 LEU A 128 PHE A 142 1 15
HELIX 8 AA8 SER A 157 LEU A 161 5 5
HELIX 9 AA9 TRP A 167 GLU A 188 1 22
HELIX 10 AB1 THR A 203 SER A 213 1 11
HELIX 11 AB2 ASP A 215 LYS A 228 1 14
HELIX 12 AB3 ASP A 233 ASP A 248 1 16
HELIX 13 AB4 ARG B 17 SER B 29 1 13
HELIX 14 AB5 ASN B 43 GLU B 57 1 15
HELIX 15 AB6 ALA B 72 GLU B 85 1 14
HELIX 16 AB7 GLY B 110 LEU B 114 5 5
HELIX 17 AB8 ASP B 116 LEU B 128 1 13
HELIX 18 AB9 LEU B 128 PHE B 142 1 15
HELIX 19 AC1 SER B 157 LEU B 161 5 5
HELIX 20 AC2 TRP B 167 GLU B 188 1 22
HELIX 21 AC3 THR B 203 SER B 213 1 11
HELIX 22 AC4 ASP B 215 LYS B 228 1 14
HELIX 23 AC5 ASP B 233 ASP B 248 1 16
SHEET 1 AA1 7 ARG A 62 PRO A 67 0
SHEET 2 AA1 7 VAL A 36 ALA A 41 1 N LEU A 39 O VAL A 66
SHEET 3 AA1 7 ALA A 8 LEU A 12 1 N CYS A 10 O VAL A 38
SHEET 4 AA1 7 ARG A 94 ASN A 99 1 O ILE A 98 N LEU A 11
SHEET 5 AA1 7 ASN A 149 ILE A 155 1 O VAL A 153 N ASN A 99
SHEET 6 AA1 7 ARG A 192 ALA A 197 1 O ARG A 192 N ARG A 150
SHEET 7 AA1 7 ALA A 254 ASP A 257 1 O VAL A 256 N ASN A 195
SHEET 1 AA2 7 ARG B 62 PRO B 67 0
SHEET 2 AA2 7 VAL B 36 ALA B 41 1 N LEU B 37 O ARG B 62
SHEET 3 AA2 7 ALA B 8 THR B 13 1 N CYS B 10 O VAL B 38
SHEET 4 AA2 7 ARG B 94 ASN B 99 1 O ILE B 98 N LEU B 11
SHEET 5 AA2 7 ASN B 149 ILE B 155 1 O THR B 151 N LEU B 95
SHEET 6 AA2 7 VAL B 191 ALA B 197 1 O ARG B 192 N ARG B 150
SHEET 7 AA2 7 HIS B 255 ASP B 257 1 O VAL B 256 N ASN B 195
SITE 1 AC1 35 GLY A 14 SER A 16 ARG A 17 GLY A 18
SITE 2 AC1 35 PHE A 19 ALA A 41 ARG A 42 ASN A 43
SITE 3 AC1 35 ALA A 68 ASP A 69 LEU A 70 ASN A 100
SITE 4 AC1 35 ALA A 101 LEU A 126 ILE A 155 SER A 156
SITE 5 AC1 35 TYR A 170 LYS A 174 PRO A 198 GLY A 199
SITE 6 AC1 35 PRO A 200 LEU A 201 THR A 203 MET A 205
SITE 7 AC1 35 GLN A 206 H4H A 302 EDO A 303 HOH A 407
SITE 8 AC1 35 HOH A 431 HOH A 437 HOH A 442 HOH A 444
SITE 9 AC1 35 HOH A 451 HOH A 466 HOH A 468
SITE 1 AC2 13 SER A 157 LEU A 158 CYS A 159 PHE A 164
SITE 2 AC2 13 TYR A 170 GLY A 199 PRO A 200 GLN A 206
SITE 3 AC2 13 ALA A 209 LEU A 222 LEU A 225 NAP A 301
SITE 4 AC2 13 HOH A 478
SITE 1 AC3 5 ARG A 17 ASP A 204 MET A 205 NAP A 301
SITE 2 AC3 5 HOH A 491
SITE 1 AC4 5 SER A 103 LEU A 104 GLY A 105 LEU A 208
SITE 2 AC4 5 HOH A 437
SITE 1 AC5 7 GLU A -6 GLY A 6 ARG A 7 SER A 32
SITE 2 AC5 7 GLN A 93 HOH A 404 GLN B 162
SITE 1 AC6 34 GLY B 14 SER B 16 ARG B 17 GLY B 18
SITE 2 AC6 34 PHE B 19 ALA B 41 ARG B 42 ASN B 43
SITE 3 AC6 34 ALA B 68 ASP B 69 LEU B 70 ASN B 100
SITE 4 AC6 34 LEU B 126 ILE B 155 SER B 156 TYR B 170
SITE 5 AC6 34 LYS B 174 PRO B 198 GLY B 199 LEU B 201
SITE 6 AC6 34 THR B 203 ASP B 204 MET B 205 GLN B 206
SITE 7 AC6 34 H4H B 302 EDO B 303 HOH B 414 HOH B 430
SITE 8 AC6 34 HOH B 438 HOH B 443 HOH B 452 HOH B 453
SITE 9 AC6 34 HOH B 473 HOH B 476
SITE 1 AC7 12 PHE A -2 TYR A -3 SER B 157 LEU B 158
SITE 2 AC7 12 CYS B 159 TYR B 170 GLN B 206 ALA B 209
SITE 3 AC7 12 LEU B 222 LEU B 225 NAP B 301 HOH B 481
SITE 1 AC8 3 ARG B 17 ASP B 204 NAP B 301
SITE 1 AC9 5 SER B 103 LEU B 104 GLY B 105 LEU B 208
SITE 2 AC9 5 HOH B 438
SITE 1 AD1 3 ASP B 69 GLY B 71 ASN B 122
SITE 1 AD2 4 GLU A 73 GLN A 77 SER B 115 SER B 117
CRYST1 113.913 77.321 59.214 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008779 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012933 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016888 0.00000